...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential
【24h】

Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential

机译:新型吲哚基吲哚的治疗研究:血管紧张素转化酶抑制剂具有心血管调控的药物靶标验证和结构 - 活性关系

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract A family of 12 members of Naphthalene-2-ol-indolin-2-one-thiocarbamides ( 5a-l ) with pharmacological potentials of cardiovascular modulator were efficiently synthesized and evaluated. These compounds show inhibitory activity on angiotensin-converting enzyme (ACE), which is a principal constituent of the renin–angiotensin system and causative source for hypertension (HTN) (elevated blood pressure) and congestive heart failure (CHF), a parameter that was tested in this report. Prior to this, to get more insight into the binding mode and inhibition of human ACE C-domain (PDB ID: 2XY9 ) and N-domain (PDB ID: 3NXQ ) compounds 5a-l was docked into the active site of them. The established inhibitory constant ( Ki ) (range 40–500?nM) and least binding affinities (?18.52 to??30.57?kcal/mol) indicated the therapeutic selectivity of compounds 5a-l towards ACE C-domain inhibition over ACE N-domain. The cytotoxicity effect of most potent compounds among 5a-l were tested in normal breast cells and MCF-7?cell lines. Simultaneously, H 2 O 2 induced antioxidant and DNA damage assessment was executed. Eventually, a thrombolytic activity followed by a human red blood cell (HRBC) membrane stabilization study to ensure the relaxation of blood and stabilization of RBC was executed. Structure-Activity Relationship (SAR) study discloses the potential of 5c , 5h, and 5k as cardiovascular protective therapeutic agents among 5a-l . Graphical abstract Display Omitted Highlights ? A family of 12 members of Naphthalene-2-ol-indolin-2-one-thiocarbamides ( 5a-l ) with pharmacological potentials of cardiovascular modulator were efficiently synthesized and evaluated. ? Angiotensin converting enzyme was effectively inhibited by 5c, 5h, 5k and 5l. ? H 2 O 2 was readily scavenged by 5a-l. ? Cardiovascular protection was ensured by thrombolytic, HRBC membrane protection and cytotoxicity mechanisms.
机译:摘要有效地合成和评估了一种具有心血管调节剂的药理潜力的萘-2-奥替洛林-2-一硫代氨基甲酰胺(5A-L)的12种系列。这些化合物显示出对血管紧张素转化酶(ACE)的抑制活性,这是肾素 - 血管紧张素系统的主要成分和高血压(HTN)(HTN)(血压升高)和充血性心力衰竭(CHF)的原因来源,是一种参数在本报告中进行了测试。在此之前,为了更高的洞察力进入结合模式和人ACE C-结构域(PDB ID:2xY9)和N-结构域(PDB ID:3NXQ)化合物5A-L的抑制作用在它们的活性位点。已建立的抑制常数(Ki)(范围40-500→Nm)和最小结合亲和力(α18.52至30.57 kcal / mol)表明了化合物5a-l对Ace n-达到ace c-域抑制的治疗选择性领域。在正常的乳腺细胞和MCF-7中测试5a-L中最有效化合物的细胞毒性效应。同时,执行H 2 O 2诱导的抗氧化剂和DNA损伤评估。最终,对人红细胞(HRBC)膜稳定研究之后的溶栓活性,以确保进行血液的放松和RBC的稳定化。结构 - 活性关系(SAR)研究公开了5C,5H和5K的电位,如5A-L中的心血管保护治疗剂。图形抽象显示省略了亮点?有效地合成和评估了具有心血管调节剂的药理学潜力的萘-2-奥替洛林-2-一硫代氨基甲酰胺(5a-L)的12种系列。还是血管紧张素转化酶被5℃,5h,5k和5L有效抑制。还是H 2 O 2易于清除5A-L.还是通过溶栓,HRBC膜保护和细胞毒性机制确保心血管保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号